This element explores the common medications prescribed for individuals with dementia, such as cholinesterase inhibitors and memantine, alongside treatment
Topic Synopsis
This element explores the common medications prescribed for individuals with dementia, such as cholinesterase inhibitors and memantine, alongside treatments for associated symptoms like depression or agitation. It emphasises the critical integration of a person-centred approach, ensuring that medication administration respects the individual's unique preferences, needs, and life history to promote dignity and well-being. Practical application involves assessing capacity, obtaining valid consent, and monitoring for both therapeutic benefits and adverse effects while maintaining clear, compassionate communication.
Key Concepts & Core Principles
- Person-centred care: Tailoring support to the individual's preferences, history, and needs, rather than focusing solely on the condition.
- Types of dementia: Understanding Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, including their symptoms and progression.
- Communication strategies: Using verbal and non-verbal techniques, such as simple language, validation, and active listening, to reduce confusion and distress.
- The Mental Capacity Act 2005: Ensuring individuals are supported to make their own decisions where possible, and using best interests principles when they cannot.
- Challenging behaviour: Recognising that behaviours like aggression or wandering often stem from unmet needs, pain, or environmental factors, and responding with de-escalation techniques.
Exam Tips & Revision Strategies
- When describing person-centred care, always link it to a named individual from your experience or a case study, detailing exactly how their preferences shaped the medication process.
- Be explicit about the legal framework (Mental Capacity Act, DoLS) and how it applies to consent and best interest decisions, as this demonstrates applied knowledge.
- In written answers, use the 'POA' (Plan, Observe, Act) structure: outline your planned approach, how you observed the individual's response, and what action you took, including any adjustments made.
Common Misconceptions & Mistakes to Avoid
- Confusing the uses of different medication types, such as assuming antidepressants directly treat dementia progression rather than co-occurring depression.
- Overlooking the necessity to record non-administration and the reasons for refusal, which compromises legal and care quality standards.
- Failing to involve the individual in decisions about their medication, defaulting to a task-focused routine that neglects person-centred principles.
Examiner Marking Points
- Award credit for demonstrating accurate knowledge of at least two common dementia medications (e.g., donepezil, rivastigmine, memantine) and their intended therapeutic effects.
- Award credit for providing clear evidence of how a person-centred approach was applied during medication administration, including specific examples of adapting support to an individual's communication style, preferences, or routines.
- Award credit for explaining the importance of obtaining consent (in line with the Mental Capacity Act) and recognising the individual's right to refuse medication, with documentation of the rationale and next steps.